Gene expressions of antiinflammatory mediators in THR retrieved interfacial membranes.
暂无分享,去创建一个
S Hukuda | S. Hukuda | K. Inoue | M Nabae | K Inoue | T Ushiyama | T. Ushiyama | M. Nabae
[1] S. Esnault,et al. Differential spontaneous expression of mRNA for IL‐4, IL‐10, IL‐13, IL‐2 and interferon‐gamma (IFN‐γ) in peripheral blood mononuclear cells (PBMC) from atopic patients , 1996, Clinical and experimental immunology.
[2] M. Gayle,et al. Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. March,et al. Cloning the interleukin 1 receptor from human T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[4] A H Burstein,et al. Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. , 1993, The Journal of bone and joint surgery. American volume.
[5] N. Rushton. Implant wear: the future of total joint replacement.: Edited by Timothy Wright and Stuart B. Goodman. Pp 150. Rosemont, Illinois: American Academy of Orthopaedic Surgeons 1996. ISBN: 0-89203-207-3. US$79.95. , 1999 .
[6] P. Tang,et al. Evidence for oestrogenic regulation of heat shock protein expression in human endometrium and steroid-responsive cell lines. , 1995, European journal of endocrinology.
[7] J. Pelletier,et al. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[8] G. Winterrowd,et al. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. , 1993, Journal of immunology.
[9] D. Walmer,et al. Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA. , 1992, The Journal of clinical endocrinology and metabolism.
[10] S. Santavirta,et al. Cytokines in aseptic loosening of total hip replacement , 1997 .
[11] J. Punnonen,et al. Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. , 1996, Arthritis and rheumatism.
[12] D. Dripps,et al. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. , 1991, The Journal of biological chemistry.
[13] K. Huebner,et al. A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. , 1991, The EMBO journal.
[14] W H Harris,et al. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. , 1993, The Journal of bone and joint surgery. American volume.
[15] G. Firestein,et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[16] M. Burdick,et al. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. , 1995, The Journal of clinical investigation.
[17] W. Scherbaum,et al. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). , 1996, Thyroid : official journal of the American Thyroid Association.
[18] B. Fleischer,et al. Interleukin‐10 prevents experimental allergic encephalomyelitis in rats , 1994, European journal of immunology.
[19] L. Shapiro,et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. , 1995, Journal of immunology.
[20] M. Bolander,et al. Oligoclonal T-cell proliferation and interferon-gamma production in periprosthetic inflammation. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[21] A. Butch,et al. Cytokine expression by germinal center cells. , 1993, Journal of immunology.
[22] Karen E. Johnson,et al. Interleukin 10 (IL-10) and Viral IL-10 Strongly Reduce Antigen-specific Human T Cell Proliferation by Diminishing the Antigen-presenting Capacity of Monocytes via Dowm'egulation of Class H Major Histocompatibility Complex Expression By Ren6 de Waal Malefyt, John Haanen, Hergen Spits, , 1991 .
[23] S. Santavirta,et al. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty. , 1997, The Journal of rheumatology.
[24] J. Banchereau,et al. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. , 1995, Journal of immunology.
[25] W. Arend,et al. Interleukin-1 receptor antagonist production by human keratinocytes. , 1992, The Journal of investigative dermatology.
[26] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[27] C. Figdor,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.
[28] S. Haskill,et al. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Santavirta,et al. Basic fibroblast growth factor (bFGF) in the synovial-like membrane around loose total hip prostheses. , 1996, Scandinavian journal of rheumatology.